Trifecta Capital Advisors, LLC Ark Genomic Revolution ETF (De Transaction History
Trifecta Capital Advisors, LLC
- $452 Billion
- Q2 2024
A detailed history of Trifecta Capital Advisors, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 465 shares of ARKG stock, worth $11,917. This represents 0.0% of its overall portfolio holdings.
Number of Shares
465
Previous 465
-0.0%
Holding current value
$11,917
Previous $13.4 Million
18.36%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
307Shares Held
20.9MCall Options Held
2.79MPut Options Held
6.56M-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$70.6 Million3.23% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$57.8 Million0.0% of portfolio
-
Ubs Group Ag1.75MShares$44.8 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.54MShares$39.4 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.46MShares$37.3 Million0.0% of portfolio